Search research articles
Contact Us
Filters
Showing results (161-170 of 169) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 169 results.
Cell Reports. Medicine
|
October 16, 2024
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinoma
Xiong Zou, Xi Ding, Zheng-Kai Feng, et al.
Therapeutic Advances in Medical Oncology
|
July 21, 2022
Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study
Meng-Xia Zhang, Ting Liu, Rui You, et al.
International Journal of Biological Macromolecules
|
March 18, 2026
Integrated expression of d-allulose 3-epimerase in Bacillus subtilis via the random integration system
Long-Tao Wang, Zun Tao, Yuan Zhang, et al.
Cell Reports. Medicine
|
November 11, 2023
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial
Si-Yuan Chen, Xiao-Tong Duan, Hui-Feng Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 4, 2025
Radiation-induced rhinosinusitis in patients with nasopharyngeal carcinoma
Si-Yuan Chen, Xiao-Tong Duan, Rui-Ling Xie, et al.
NEJM Evidence
|
April 22, 2025
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma
Pei-Yu Huang, Xu-Yin Chen, Xi Ding, et al.
BMJ (Clinical Research Ed.)
|
February 10, 2026
Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial
Rui You, Gui-Qiong Xu, Xi Ding, et al.
Cancer Research
|
December 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma
Yige Wu, Siqi Chen, Xiaolu Yang, et al.
Lancet (London, England)
|
February 26, 2023
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Rui You, You-Ping Liu, Yu-Long Xie, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 169) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 169 results.
Cell Reports. Medicine
|
October 16, 2024
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinoma
Xiong Zou, Xi Ding, Zheng-Kai Feng, et al.
Therapeutic Advances in Medical Oncology
|
July 21, 2022
Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study
Meng-Xia Zhang, Ting Liu, Rui You, et al.
International Journal of Biological Macromolecules
|
March 18, 2026
Integrated expression of d-allulose 3-epimerase in Bacillus subtilis via the random integration system
Long-Tao Wang, Zun Tao, Yuan Zhang, et al.
Cell Reports. Medicine
|
November 11, 2023
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial
Si-Yuan Chen, Xiao-Tong Duan, Hui-Feng Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 4, 2025
Radiation-induced rhinosinusitis in patients with nasopharyngeal carcinoma
Si-Yuan Chen, Xiao-Tong Duan, Rui-Ling Xie, et al.
NEJM Evidence
|
April 22, 2025
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma
Pei-Yu Huang, Xu-Yin Chen, Xi Ding, et al.
BMJ (Clinical Research Ed.)
|
February 10, 2026
Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial
Rui You, Gui-Qiong Xu, Xi Ding, et al.
Cancer Research
|
December 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma
Yige Wu, Siqi Chen, Xiaolu Yang, et al.
Lancet (London, England)
|
February 26, 2023
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Rui You, You-Ping Liu, Yu-Long Xie, et al.
Page
of 17